Periostat data

The Newton, Penn., company reported statistically significant slowing of the loss of bone attachment with the tetracycline drug.

As presented at the Cowen & Co. conference in Boston, the Phase III trial in 437 patients had significant changes (as much as p<0.005) in two of the three protocols tested. ...